rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6
|
pubmed:dateCreated |
2002-12-4
|
pubmed:abstractText |
We report on 2 patients with idiopathic Parkinson's disease who experienced marked improvement in symptoms following the addition of itraconazole to current cabergoline treatment. Plasma levels of cabergoline were analyzed in one of the patients and increased to approximately 300% during treatment with itraconazole, which paralleled major clinical improvement.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0885-3185
|
pubmed:author |
|
pubmed:copyrightInfo |
Copyright 2002 Movement Disorder Society
|
pubmed:issnType |
Print
|
pubmed:volume |
17
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1360-2
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:12465083-Adult,
pubmed-meshheading:12465083-Aged,
pubmed-meshheading:12465083-Antifungal Agents,
pubmed-meshheading:12465083-Antiparkinson Agents,
pubmed-meshheading:12465083-Cytochrome P-450 CYP3A,
pubmed-meshheading:12465083-Cytochrome P-450 Enzyme System,
pubmed-meshheading:12465083-Dose-Response Relationship, Drug,
pubmed-meshheading:12465083-Drug Interactions,
pubmed-meshheading:12465083-Drug Therapy, Combination,
pubmed-meshheading:12465083-Ergolines,
pubmed-meshheading:12465083-Female,
pubmed-meshheading:12465083-Humans,
pubmed-meshheading:12465083-Itraconazole,
pubmed-meshheading:12465083-Male,
pubmed-meshheading:12465083-Neurologic Examination,
pubmed-meshheading:12465083-Onychomycosis,
pubmed-meshheading:12465083-Parkinson Disease,
pubmed-meshheading:12465083-Treatment Outcome
|
pubmed:year |
2002
|
pubmed:articleTitle |
Cabergoline plasma concentration is increased during concomitant treatment with itraconazole.
|
pubmed:affiliation |
Centre for Clinical Pharmacology, University of Aarhus, Aarhus, Denmark. Jakob@farm.au.dk
|
pubmed:publicationType |
Journal Article,
Case Reports
|